(Shares rose nearly 2% in early trading. The move higher comes one day after the biotech company said its new Covid vaccine is effective against the Eris variant of the virus. On Tuesday, the stock surged more than 13%.)
(The stock added 2.6% after beating expectations for the second quarter. The company reported adjusted earnings of 52 cents per share, while analysts polled by Refinitiv expected 22 cents. Revenue came in slightly lower, however, with the company reporting $3.68 billion against a forecast of $3.69 billion.)
(Shares of the pharmaceutical company surged nearly 30% in premarket trading after Apellis released a safety update about Syfovre, a drug used to treat a degenerative eye disease. Apellis said that no direct cause has been found between a side effect and a particular filter needle used with Syfovre, but that practitioners should use a different filter needle instead.)
(The stock rose 4.8% after the apparel retailer beat expectations for the second quarter as same-store sales rose, driven by growth in retail stores and online sales.)
(Stock in the exercise bike stock plummeted more than 27% after posting quarterly results. Peloton reported an adjusted loss of 68 cents per share on $642.1 million in revenue, while analysts polled by Refinitiv had forecasted a 38-cent loss and $639 million.)
(The stock plunged more than 32% before the bell after the sneaker retailer slashed its outlook for the second time this year. Adjusted earnings came in at 4 cents per share, in line with expectations for the fiscal second quarter, but revenues fell short of the $1.88 billion anticipated. Foot Locker also suspended its quarterly dividend.)